Quality and Innovation Position Sherman Abrams Labs as Brooklyn's leading clinical and anatomic pathology lab with a strong emphasis on innovation driven by quality, highlighting capabilities that align with potential clients seeking reliability and cutting-edge technology.

Midmarket Scale Leverage the company’s mid-size profile (51-200 employees) to target mid-market hospitals and clinics that require dedicated lab partners with personalized service and fast turnaround without the complexity of large enterprise vendors.

Revenue Stability With reported annual revenue in the mid eight-figures to low nine-figures range, identify opportunities to upsell higher-margin specialized pathology services, second-opinion programs, and rapid diagnostics to expand account value.

Geographic Focus Emphasize Brooklyn-based location to cultivate local hospital networks and regional health systems in New York City, offering on-site collaboration, flexible SLAs, and co-location opportunities for faster sample processing.

Competitive Positioning Differentiate from larger CROs by marketing agile operations, personalized client support, and state-of-the-art technology access, appealing to institutions seeking high-touch service and consistent quality over scale.